Publications by authors named "Josh Mailman"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

198

Total Likes

314

Extended Reach

659,201

Social Features

120
P
Personal Health Record Software for Neuroendocrine Tumors: Patient-Centered Design Approach.
Juan Pablo Hourcade, Michael O'Rorke, Elizabeth Chrischilles, Nicholas J Rudzianski, Brian Gryzlak, Josh A Mailman

JMIR Hum Factors· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.
Kimberly Perez, Jaydira Del Rivero, Erin B Kennedy, Sandip Basu, Aman Chauhan, Josh Mailman

JCO Oncol Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET.
Simron Singh, Diego Ferone, Jaume Capdevila, Jennifer Ang Chan, Wouter W de Herder, Josh Mailman

Trials· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials.
Morgan R L Lichtenstein, Laura A Levit, Caroline Schenkel, Kelsey Kirkwood, Lola A Fashoyin-Aje, Josh A Mailman

Oncologist· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET.
Simron Singh, Diego Ferone, Jaume Capdevila, Jennifer Ang Chan, Wouter W de Herder, Josh Mailman

Trials· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care.
Jaydira Del Rivero, Josh Mailman, Michael W Rabow, Jennifer A Chan, Sarah Creed

Endocr Relat Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumors.
Boris G Naraev, Josh Mailman, Thorvardur R Halfdanarson, Heloisa P Soares, Erik S Mittra

Expert Rev Anticancer Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Advocates and Researchers as Partners in Cancer Research: A Winning Combination.
Laura D Porter, Karyn A Goodman, Josh Mailman, Wendy S Garrett

Am Soc Clin Oncol Educ Book· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Education Competencies for Integrative Oncology-Results of a Systematic Review and an International and Interprofessional Consensus Procedure.
Claudia M Witt, Lynda G Balneaves, Linda E Carlson, Misha Cohen, Gary Deng, Josh Mailman

J Cancer Educ· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leadership in Patient Advocacy: A Conversation Between Josh Mailman and Thomas Hope.
Josh Mailman, Thomas A Hope

J Nucl Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ICPO Foundation-on the way toward collaborative growth of theranostics.
Richard P Baum, Josh Mailman, Odile Jaume

Eur J Nucl Med Mol Imaging· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Framework for Patient-Centered Pathways of Care for Radiopharmaceutical Therapy: An ASTRO Consensus Document.
John M Buatti, Daniel A Pryma, Ana P Kiess, Josh Mailman, Ronald D Ennis

Int J Radiat Oncol Biol Phys· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
North American Neuroendocrine Tumor Society Guide for Neuroendocrine Tumor Patient Health Care Providers During COVID-19.
Emily K Bergsland, Daniel M Halperin, Joseph S Dillon, N Arvind Dasari, Pamela L Kunz, Josh Mailman

Pancreas· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Travel Concerns After Treatment with Lu-DOTATATE.
Ayşe Tuba Kendi, Josh A Mailman, Boris G Naraev, David J Mercer, James K Underwood

J Nucl Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of Lu-DOTATATE Peptide Receptor Radionuclide Therapy.
Thomas A Hope, Lisa Bodei, Jennifer A Chan, Ghassan El-Haddad, Nicholas Fidelman, Josh Mailman

J Nucl Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.
Thomas A Hope, Emily K Bergsland, Murat Fani Bozkurt, Michael Graham, Anthony P Heaney, Josh Mailman

J Nucl Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comprehensive Definition for Integrative Oncology.
Claudia M Witt, Lynda G Balneaves, Maria J Cardoso, Lorenzo Cohen, Heather Greenlee, Josh Mailman

J Natl Cancer Inst Monogr· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Tools and Options for the Management of Patients with Neuroendocrine Tumors: A Patient Perspective.
Josh Mailman

J Nucl Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patients' perspective on integrative oncology: getting past the "war," living with and beyond cancer.
Josh Mailman

J Natl Cancer Inst Monogr· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis